Cargando…

Development of Proteomic Patterns for Detecting Lung Cancer

Lung cancer is at present the number one cause of cancer death and no biomarker is available to detect early lung cancer in serum samples so far. The objective of this study is to find specific biomarkers for detection of lung cancer using Surface Enhanced Laser Desorption/Ionization (SELDI) technol...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Xueyuan, Liu, Danhui, Tang, Ying, Guo, Fuzheng, Xia, Liang, Liu, Jin, He, Dacheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2003
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851077/
https://www.ncbi.nlm.nih.gov/pubmed/14757945
http://dx.doi.org/10.1155/2003/278152
_version_ 1782294219897962496
author Xiao, Xueyuan
Liu, Danhui
Tang, Ying
Guo, Fuzheng
Xia, Liang
Liu, Jin
He, Dacheng
author_facet Xiao, Xueyuan
Liu, Danhui
Tang, Ying
Guo, Fuzheng
Xia, Liang
Liu, Jin
He, Dacheng
author_sort Xiao, Xueyuan
collection PubMed
description Lung cancer is at present the number one cause of cancer death and no biomarker is available to detect early lung cancer in serum samples so far. The objective of this study is to find specific biomarkers for detection of lung cancer using Surface Enhanced Laser Desorption/Ionization (SELDI) technology. In this study, serum samples from 30 lung cancer patients and 51 age-and sex-matched healthy were analyzed by SELDI based ProteinChip reader, PBSII-C. The spectra were generated on WCX2 chips and protein peaks clustering and classification analyses were performed utilizing Biomarker Wizard and Biomarker Patterns software packages, respectively. Three protein peaks were automatically chosen for the system training and the development of a decision classification tree. The constructed model was then used to test an independent set of masked serum samples from 15 lung cancer patients and 31 healthy individuals. The analysis yielded a sensitivity of 93.3%, and a specificity of 96.7%. These results suggest that the serum is a capable resource for detection of specific lung cancer biomarkers. SELDI technique combined with an artificial intelligence classification algorithm can both facilitate the discovery of better biomarkers for lung cancer and provide a useful tool for molecular diagnosis in future.
format Online
Article
Text
id pubmed-3851077
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-38510772013-12-17 Development of Proteomic Patterns for Detecting Lung Cancer Xiao, Xueyuan Liu, Danhui Tang, Ying Guo, Fuzheng Xia, Liang Liu, Jin He, Dacheng Dis Markers Other Lung cancer is at present the number one cause of cancer death and no biomarker is available to detect early lung cancer in serum samples so far. The objective of this study is to find specific biomarkers for detection of lung cancer using Surface Enhanced Laser Desorption/Ionization (SELDI) technology. In this study, serum samples from 30 lung cancer patients and 51 age-and sex-matched healthy were analyzed by SELDI based ProteinChip reader, PBSII-C. The spectra were generated on WCX2 chips and protein peaks clustering and classification analyses were performed utilizing Biomarker Wizard and Biomarker Patterns software packages, respectively. Three protein peaks were automatically chosen for the system training and the development of a decision classification tree. The constructed model was then used to test an independent set of masked serum samples from 15 lung cancer patients and 31 healthy individuals. The analysis yielded a sensitivity of 93.3%, and a specificity of 96.7%. These results suggest that the serum is a capable resource for detection of specific lung cancer biomarkers. SELDI technique combined with an artificial intelligence classification algorithm can both facilitate the discovery of better biomarkers for lung cancer and provide a useful tool for molecular diagnosis in future. IOS Press 2003 2004-02-02 /pmc/articles/PMC3851077/ /pubmed/14757945 http://dx.doi.org/10.1155/2003/278152 Text en Copyright © 2003 Hindawi Publishing Corporation.
spellingShingle Other
Xiao, Xueyuan
Liu, Danhui
Tang, Ying
Guo, Fuzheng
Xia, Liang
Liu, Jin
He, Dacheng
Development of Proteomic Patterns for Detecting Lung Cancer
title Development of Proteomic Patterns for Detecting Lung Cancer
title_full Development of Proteomic Patterns for Detecting Lung Cancer
title_fullStr Development of Proteomic Patterns for Detecting Lung Cancer
title_full_unstemmed Development of Proteomic Patterns for Detecting Lung Cancer
title_short Development of Proteomic Patterns for Detecting Lung Cancer
title_sort development of proteomic patterns for detecting lung cancer
topic Other
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851077/
https://www.ncbi.nlm.nih.gov/pubmed/14757945
http://dx.doi.org/10.1155/2003/278152
work_keys_str_mv AT xiaoxueyuan developmentofproteomicpatternsfordetectinglungcancer
AT liudanhui developmentofproteomicpatternsfordetectinglungcancer
AT tangying developmentofproteomicpatternsfordetectinglungcancer
AT guofuzheng developmentofproteomicpatternsfordetectinglungcancer
AT xialiang developmentofproteomicpatternsfordetectinglungcancer
AT liujin developmentofproteomicpatternsfordetectinglungcancer
AT hedacheng developmentofproteomicpatternsfordetectinglungcancer